JeffreyBerinsteinMDMSc

Inflammatory Bowel Disease

Assistant Professor

Dr. Berinstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Jeffrey Berinstein is a clinician scientist and gastroenterologist at the University of Michigan. He completed his residency in internal medicine and fellowship in gastroenterology and hepatology at the University of Michigan (Michigan Medicine). He specializes in caring for patients with inflammatory bowel diseases.

PubMed

Disparities in Vaccination Amongst Socially Vulnerable Patients with Inflammatory Bowel Disease.
Jessica L Sheehan, Ariel A Jordan, Kira L Newman, Laura A Johnson, Dala Eloubeidi
Digestive Diseases and Sciences. 2024-11-15
Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways.
Jonathan Golob, Krishna Rao, Jeffrey A Berinstein, Prashant Singh, William D Chey
Inflammatory Bowel Diseases. 2024-11-14
1 citations
Use of Upadacitinib in 16 Tofacitinib-refractory Ulcerative Colitis Patients: A Single-center Case 2Series.
Jake Levine, Jey McKibbin, Rebecca Ham, Shirley Cohen-Mekelburg, Shrinivas Bishu
Inflammatory Bowel Diseases. 2024-11-04

IBD Symptoms May Show up Years Before Clinical Diagnosis, Study ShowsMarch 6th, 2023
Can Coordinated Care Help Patients with High-Risk IBD?May 2nd, 2022
Patient-Centered IBD Care Made No Dent in Healthcare CostsSeptember 2nd, 2021
Join now to see all